603020.SH
爱普股份
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 9.86
−1.99%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.5B | 2.5B | 2.7B | 2.8B | 3.2B |
| Cost of Revenue | 2.1B | 2.1B | 2.2B | 2.4B | 2.7B |
| Gross Profit | 364.3M | 367.5M | 442.1M | 412.4M | 461.9M |
| Operating Expenses | |||||
| R&D Expense | 24.5M | 26.8M | 32.3M | 34.5M | 44.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 117.8M | 116.7M | 133.0M | 146.7M | 146.3M |
| Selling & Marketing Expense | 96.5M | 99.3M | 107.7M | 107.8M | 106.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 254.2M | 258.3M | 277.4M | 294.1M | 302.3M |
| Cost and Expenses | 2.4B | 2.4B | 2.5B | 2.7B | 3.0B |
| Operating Income (EBIT) | 148.7M | 152.0M | 246.9M | 142.4M | 175.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 150.2M | 153.6M | 246.3M | 141.9M | 165.3M |
| Income Tax Expense | 34.0M | 36.3M | 55.2M | 30.5M | 40.7M |
| Bottom Line | |||||
| Net Income | 87.5M | 86.7M | 159.1M | 90.8M | 110.0M |
| Earnings from Cont. Ops | 116.2M | 117.2M | 191.1M | 109.4M | 133.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 87.5M | 86.7M | 159.1M | 90.8M | 110.0M |
| Per Share | |||||
| Basic EPS | CN¥0.23 | CN¥0.23 | CN¥0.42 | CN¥0.24 | CN¥0.29 |
| Diluted EPS | CN¥0.23 | CN¥0.23 | CN¥0.42 | CN¥0.24 | CN¥0.29 |
| Revenue Per Share | CN¥6.63 | CN¥6.57 | CN¥7.14 | CN¥7.41 | CN¥8.42 |
| Shares | |||||
| Basic Shares Outstanding | 375.6M | 375.7M | 375.6M | 375.7M | 380.3M |
| Diluted Shares Outstanding | 375.6M | 375.7M | 375.6M | 375.7M | 380.3M |
| Profitability Metrics | |||||
| EBITDA | — | 218.0M | 325.5M | 206.1M | 229.9M |
| D&A | — | 66.1M | 78.6M | 63.7M | 54.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026